Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Raw Materials (2019 - 2022)

Marimed (MRMD) has disclosed Raw Materials for 4 consecutive years, with $2.4 million as the latest value for Q1 2022.

  • On a quarterly basis, Raw Materials fell 35.03% to $2.4 million in Q1 2022 year-over-year; TTM through Mar 2022 was $2.4 million, a 35.03% decrease, with the full-year FY2021 number at $1.0 million, down 69.72% from a year prior.
  • Raw Materials was $2.4 million for Q1 2022 at Marimed, up from $1.0 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $3.7 million in Q1 2021 to a low of $245353.0 in Q2 2021.
  • A 4-year average of $1.8 million and a median of $1.5 million in 2021 define the central range for Raw Materials.
  • Peak YoY movement for Raw Materials: soared 748.36% in 2020, then plummeted 69.72% in 2021.
  • Marimed's Raw Materials stood at $395167.0 in 2019, then skyrocketed by 748.36% to $3.4 million in 2020, then tumbled by 69.72% to $1.0 million in 2021, then soared by 137.73% to $2.4 million in 2022.
  • Per Business Quant, the three most recent readings for MRMD's Raw Materials are $2.4 million (Q1 2022), $1.0 million (Q4 2021), and $1.5 million (Q3 2021).